| The critical role of RNA m6A methylation in cancer Q Lan, PY Liu, J Haase, JL Bell, S Hüttelmaier, T Liu Cancer research 79 (7), 1285-1292, 2019 | 556 | 2019 |
| IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner S Müller, M Glaß, AK Singh, J Haase, N Bley, T Fuchs, M Lederer, A Dahl, ... Nucleic acids research 47 (1), 375-390, 2019 | 299 | 2019 |
| The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer S Müller, N Bley, B Busch, M Glaß, M Lederer, C Misiak, T Fuchs, ... Nucleic acids research 48 (15), 8576-8590, 2020 | 101 | 2020 |
| Comprehensive analysis of translation from overexpressed circular RNAs reveals pervasive translation from linear transcripts H Ho-Xuan, P Glažar, C Latini, K Heizler, J Haase, R Hett, M Anders, ... Nucleic acids research 48 (18), 10368-10382, 2020 | 60 | 2020 |
| Deep and accurate detection of m6A RNA modifications using miCLIP2 and m6Aboost machine learning N Körtel, C Rücklé, Y Zhou, A Busch, P Hoch-Kraft, FXR Sutandy, J Haase, ... Nucleic acids research 49 (16), e92-e92, 2021 | 59 | 2021 |
| IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis J Haase, D Misiak, M Bauer, N Pazaitis, J Braun, R Pötschke, A Mensch, ... Modern Pathology 34 (1), 32-41, 2021 | 31 | 2021 |
| Synthetic circular miR-21 RNA decoys enhance tumor suppressor expression and impair tumor growth in mice S Müller, A Wedler, J Breuer, M Glaß, N Bley, M Lederer, J Haase, ... NAR cancer 2 (3), zcaa014, 2020 | 15 | 2020 |
| MSI1 promotes the expression of the GBM stem cell marker CD44 by impairing miRNA-dependent degradation R Pötschke, J Haase, M Glaß, S Simmermacher, C Misiak, LOF Penalva, ... Cancers 12 (12), 3654, 2020 | 11 | 2020 |
| Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes A Bikas, S Ahmadi, T Pappa, E Marqusee, K Wong, MA Nehs, NL Cho, ... Clinical Cancer Research 29 (14), 2678-2685, 2023 | 6 | 2023 |
| Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects I Landa, CEM Thornton, B Xu, J Haase, GP Krishnamoorthy, J Hao, ... Molecular Cancer Research 21 (11), 1163-1175, 2023 | 4 | 2023 |
| MiRNA deregulation distinguishes anaplastic thyroid carcinoma (ATC) and supports upregulation of oncogene expression D Misiak, M Bauer, J Lange, J Haase, J Braun, K Lorenz, C Wickenhauser, ... Cancers 13 (23), 5913, 2021 | 4 | 2021 |
| Papillary thyroid carcinomas with tall cell features: an intermediate entity between classic and tall cell subtypes A Bikas, K Wong, T Pappa, S Ahmadi, CB Wakefield, E Marqusee, ... Thyroid 33 (6), 697-704, 2023 | 1 | 2023 |
| Telomerase reactivation induces progression of mouse BrafV600E-driven thyroid cancers without telomere lengthening I Landa, CEM Thornton, B Xu, J Haase, GP Krishnamoorthy, J Hao, ... bioRxiv, 2023 | 1 | 2023 |
| CREBBP/EP300 disruption promotes tumor progression and confers synthetic lethality in anaplastic thyroid cancers J Haase, TA Gebhard, Q Liu, SG Bernabé, J Hao, C Unegbu, A Bikas, J Qi, ... Cancer Research 83 (7_Supplement), 3068-3068, 2023 | | 2023 |
| OR17-1 MKRN3 Inhibits the Reproductive Axis by Interacting With Key Hypothalamic Substrates and Targeting Neurokinin B to Degradation Pathways. AP Abreu, RS Carroll, J Haase, UB Kaiser, I Landa, JC Magnotto, L Naulé, ... Journal of the Endocrine Society 6 (Supplement_2), A616-A616, 2022 | | 2022 |
| IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma and an enhancer of a targetable gene expression signature J Haase | | 2020 |
